SCHEMBL7185708

SCHEMBL7185708

CCCc1ccc(OC(C)(C)C)c(/C=C/C(=O)c2ccc(N)cc2)c1OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
KRAS P01116 1/20 0.43
CTSL P07711 1/20 0.39
CTSB P07858 1/20 0.39
CYP1B1 Q16678 1/20 0.39
ABCG2 Q9UNQ0 4/20 0.38
MAPT P10636 4/20 0.38
KMT2A Q03164 3/20 0.38
LMNA P02545 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
NFKB1 P19838 1/20 0.38
HTT P42858 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
PTPN1 P18031 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7185711 1.00 CA1 (0.43) CA1CA2KRASCTSLCTSB
SCHEMBL7184912 0.90 ABCG2 (0.43) CTSLCTSBABCG2MAPTKMT2A
SCHEMBL7184914 0.90 ABCG2 (0.43) CTSLCTSBABCG2MAPTKMT2A
SCHEMBL7187421 0.87 MAPT (0.38) KRASABCG2MAPTKMT2ALMNA
SCHEMBL7191587 0.87 ABCG2 (0.36) ABCG2MAPTKMT2ALMNASMN1; SMN2
SCHEMBL7191583 0.87 ABCG2 (0.36) ABCG2MAPTKMT2ALMNASMN1; SMN2
SCHEMBL7187417 0.87 MAPT (0.38) KRASABCG2MAPTKMT2ALMNA
SCHEMBL7184241 0.86 CA1 (0.42) CA1CA2KRASCTSLCTSB
SCHEMBL7184243 0.86 CA1 (0.42) CA1CA2KRASCTSLCTSB
SCHEMBL7183868 0.85 ELANE (0.40) ABCG2PTPN1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed